PMID: 15368781Sep 17, 2004Paper

Use of smoking cessation interventions and aspirin for secondary prevention: are there racial disparities?

American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
Eunice H AmbrizLaura A Petersen

Abstract

We examined whether racial differences exist in the use of aspirin and smoking cessation interventions for secondary prevention in veterans with coronary artery disease (CAD). We enrolled a total of 1045 African-American and white patients with CAD at 5 Veterans Administration hospitals between 1999 and 2001. Data were obtained by chart review. Among current smokers, African-American and white patients were equally likely to receive smoking cessation interventions (55.8% versus 56.1%; P = .97). Similarly, among ideal candidates for aspirin therapy, there was no difference in overall treatment rates between the 2 groups (74.1% versus 73.4%; P = .85). However, in the subsets of ideal candidates with hypercholesterolemia and previous stroke, African-Americans were less likely than whites to receive aspirin (P < .05). In contrast, African-Americans with hypertension were more likely than whites to receive aspirin (P = .05). Our findings highlight the need for improvement in use of smoking cessation interventions and aspirin among all patients with CAD and indicate an area where future quality improvement efforts may be warranted.

References

Mar 18, 1992·JAMA : the Journal of the American Medical Association·K C GoldbergA A Rimm
Jul 23, 1992·The New England Journal of Medicine·J LauT C Chalmers
Jul 1, 1989·Journal of Psychoactive Drugs·W Feigelman, B Gorman
Nov 15, 1993·Journal of the American College of Cardiology·H M KrumholzM C Weinstein
Dec 1, 1996·Journal of General Internal Medicine·J J AllisonR M Farmer
Feb 24, 2001·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·V Gil
Jan 22, 2002·Medical Care·Laura A Petersen
Jan 25, 2003·Journal of General Internal Medicine·Carol M AshtonRichard L Street

❮ Previous
Next ❯

Citations

Feb 28, 2008·Journal of General Internal Medicine·Somnath SahaSaid Ibrahim
Sep 29, 2011·International Journal of Stroke : Official Journal of the International Stroke Society·Alexander W DromerickChelsea S Kidwell
Dec 5, 2009·Journal of the American Academy of Nurse Practitioners·Andrea Brassard
Oct 19, 2017·Family Practice·Denise R Hooks-AndersonJeffrey F Scherrer
May 28, 2011·Stroke; a Journal of Cerebral Circulation·Salvador Cruz-FloresUNKNOWN Council on Quality of Care and Outcomes Research

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.